Cargando…
Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice
Mutations in Rhodopsin (RHO) gene commonly cause autosomal dominant retinitis pigmentosa (adRP) without effective therapeutic treatment so far. Compared with genomic DNA-targeting CRISPR-Cas9 system, Cas13 edits RNA for therapeutic applications, avoiding the risk of causing permanent changes in the...
Autores principales: | Yan, Zixiang, Yao, Yuqin, Li, Luyao, Cai, Lingqiong, Zhang, Haiwei, Zhang, Shenghai, Xiao, Qingquan, Wang, Xing, Zuo, Erwei, Xu, Chunlong, Wu, Jihong, Yang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445100/ https://www.ncbi.nlm.nih.gov/pubmed/37621413 http://dx.doi.org/10.1016/j.omtn.2023.08.002 |
Ejemplares similares
-
Disease modeling and pharmacological rescue of autosomal dominant Retinitis Pigmentosa associated with RHO copy number variation
por: Kandoi, Sangeetha, et al.
Publicado: (2023) -
Identification of a novel RHO heterozygous nonsense mutation in a Chinese family with autosomal dominant retinitis pigmentosa
por: Liu, Wei, et al.
Publicado: (2021) -
AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa
por: Shahin, Saba, et al.
Publicado: (2022) -
Gene therapy in animal models of autosomal dominant retinitis pigmentosa
por: Rossmiller, Brian, et al.
Publicado: (2012) -
SPP2 Mutations Cause Autosomal Dominant Retinitis Pigmentosa
por: Liu, Yuan, et al.
Publicado: (2015)